Press release

Featured image of the post Replicate Bioscience unveils promising clinical progress on self-amplifying RNA at ASGCT annual meeting.

Replicate Bioscience unveils promising clinical progress on self-amplifying RNA at ASGCT annual meeting

Posted on by

SOPHIA ANTIPOLIS, France – May 13, 2024 │ KnowMade actively follows therapeutic mRNA news for its Therapeutic mRNA patent monitor service! What’s new today? REPLICATE BIOSCIENCE develops novel self-amplifying RNA (or self-replicating or srRNA) technology for use across a range of application (i.e., infectious disease, oncology, or autoimmune disease). This clinical-stage company was already identified[…]

Featured image of Q12024 mRNA monitor Press release.

Q1 2024 IP Activity Reveals Growth and Litigation in Key mRNA Market

Posted on by

SOPHIA ANTIPOLIS, France – April 18, 2024 │ The quarterly report for the Q1 2024 Therapeutic mRNA patent monitor is now available! This report covers all aspects of mRNA design, delivery, manufacturing, storing, mRNA-based vaccines, and mRNA-based therapeutics. What’s new this quarter? Q1 2024 IP Activity overview The IP activity during Q1 2024 follow 2023’s[…]

Featured image of the article Unveiling the dynamics of RF acoustic wave filters patent landscape: a deep dive into a fast-moving industry

Unveiling the dynamics of RF acoustic wave filters patent landscape: a deep dive into a fast-moving industry

Posted on by

SOPHIA ANTIPOLIS, France, April 8, 2024 │ KnowMade is releasing a new RF Acoustic Wave Filter Intellectual Property (IP) report, providing a deep dive into worldwide patenting activities and showing how patents can support players’ strategies to strengthen their IP portfolio, secure their positions, and conquer new market shares. The critical role of RF acoustic[…]

Featured image of our press release upon Q4 2023 patent monitor.

Q4 2023 Therapeutic mRNA patent monitor report: IP dynamic overview

Posted on by

SOPHIA ANTIPOLIS, France – January 22, 2024 │ The quarterly report for the Q4 2023 Therapeutic mRNA patent monitor is now available! This report covers all aspects of mRNA design, delivery, manufacturing, storing, mRNA-based vaccines, and mRNA-based therapeutics. What’s new this quarter? Q4 2023 IP Activity overview The IP activity during Q4 2023 is consistent[…]